Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 282.00
Bid: 281.00
Ask: 282.00
Change: 8.50 (3.11%)
Spread: 1.00 (0.356%)
Open: 272.00
High: 282.50
Low: 272.00
Prev. Close: 273.50
MSLH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

31 Mar 2017 07:00

RNS Number : 0931B
Marshalls PLC
31 March 2017
 

 

31 March 2017

 

Directorate Changes

 

Marshalls plc ("Marshalls" or "the Company") is pleased to announce the appointment of Graham Prothero to the Board as a non-executive director, which will take effect immediately after the Annual General Meeting ("AGM") of Marshalls plc on 10 May 2017.

 

Mark Edwards, non-executive Director and Chair of the Audit Committee, who has served on the Board since May 2010, has announced his intention to retire from the Board following the close of the AGM on 10 May 2017. It is expected that Graham Prothero will succeed Mark Edwards as Chair of the Audit Committee upon Mark's retirement.

 

Graham Prothero is a Chartered Accountant and is an Executive Director and Group Chief Financial Officer of Galliford Try plc, the industry-leading FTSE 250 housebuilding, regeneration and construction group. He is also Non-Executive Deputy Chair of the Jigsaw Trust, a charitable trust. Prior to joining Galliford Try plc in 2013, he was Group Finance Director at leading property developer Development Securities PLC (now U+I), having previously held senior finance positions at Taylor Woodrow, the FTSE 100 listed housebuilder, and at Blue Circle Industries plc. Graham also spent 7 years as a partner in the Real Estate, Hospitality and Construction Group of Ernst & Young LLP. He brings current and relevant financial experience in the construction and building materials sector, as well as wider experience in an advisory professional capacity in relation to businesses operating in construction, real estate and other sectors.

 

The recruitment of Graham Prothero to succeed Mark Edwards takes place in line with the Company's Board development and succession planning strategy to regularly refresh the skills and experience around the Board table, and followed a formal, rigorous and objective process led by the Nomination Committee with the help of external consultants Lygon.

 

Andrew Allner, Chairman of Marshalls, commented: "I am delighted that Graham Prothero will be joining the Board as a non-executive director to succeed Mark Edwards. He brings broad financial and relevant sector experience and will be a valuable addition to the Board. I would also like to express our thanks to Mark Edwards, who is stepping down after 7 years' service on the Marshalls Board and as Chair of the Audit Committee. Mark's contribution to the Board and the Company is greatly appreciated".

 

Enquiries:

Andrew Allner - Chairman (Tel: 01422 314777)

Martyn Coffey - Chief Executive (Tel: 01422 314777)

Andrew Jaques / James White / Charlie Barker - MHP (Tel: 0203 128 8540)

 

Additional information:

Graham Prothero is independent for the purposes of the UK Corporate Governance Code This announcement includes the information required by Listing Rules 9.6.11 to 9.6.13, and there is no information to report under Listing Rule 9.6.13 (2) - (6) inclusive.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAURRBRBVAOOAR
Date   Source Headline
9th May 20231:06 pmRNSDirector/PDMR Shareholding
9th May 202312:31 pmRNSDirector/PDMR Shareholding
9th May 202310:34 amRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSTrading Statement
4th Apr 20238:57 amRNSAnnual Financial Report
29th Mar 202312:19 pmRNSEBT Share Purchase
20th Mar 20235:25 pmRNSDirector/PDMR Shareholding
17th Mar 20232:00 pmRNSHolding(s) in Company
17th Mar 20231:46 pmRNSDirector/PDMR Shareholding
17th Mar 202311:18 amRNSDirector/PDMR Shareholding
17th Mar 202311:17 amRNSDirector/PDMR Shareholding
17th Mar 20239:08 amRNSDirector/PDMR Shareholding
16th Mar 20232:49 pmRNSDirector/PDMR Shareholding
15th Mar 20232:45 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSFinal Results
10th Mar 20239:04 amRNSHolding(s) in Company
20th Feb 202310:42 amRNSHolding(s) in Company
16th Feb 202311:42 amRNSHolding(s) in Company
6th Feb 202311:23 amRNSHolding(s) in Company
3rd Feb 202312:51 pmRNSHolding(s) in Company
1st Feb 20232:21 pmRNSDirector/PDMR Shareholding
27th Jan 20231:32 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSTrading Statement
13th Jan 20231:55 pmRNSHolding(s) in Company
8th Nov 20222:12 pmRNSDirectorate Change
8th Nov 202212:01 pmRNSHolding(s) in Company
25th Oct 20224:27 pmRNSHolding(s) in Company
7th Oct 20223:36 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSTrading Statement
22nd Sep 20227:00 amRNSCapital Markets Day
19th Aug 20223:36 pmRNSDirector/PDMR Shareholding
18th Aug 20227:00 amRNSHalf-year Report
3rd Aug 20224:12 pmRNSHolding(s) in Company
18th Jul 202210:04 amRNSDirector/PDMR Shareholding
14th Jul 202211:51 amRNSDirector/PDMR Shareholding
12th Jul 20227:00 amRNSTrading Statement
11th May 20221:34 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
10th May 20223:14 pmRNSDirector/PDMR Shareholding
10th May 20223:02 pmRNSDirector/PDMR Shareholding
5th May 20229:19 amRNSHolding(s) in Company
3rd May 20224:20 pmRNSHolding(s) in Company
3rd May 20223:09 pmRNSDirector/PDMR Shareholding
3rd May 20223:08 pmRNSDirector/PDMR Shareholding
3rd May 20223:07 pmRNSDirector/PDMR Shareholding
3rd May 20223:06 pmRNSDirector/PDMR Shareholding
3rd May 20223:03 pmRNSDirector/PDMR Shareholding
3rd May 20223:02 pmRNSDirector/PDMR Shareholding
3rd May 20223:01 pmRNSDirector/PDMR Shareholding
3rd May 20223:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.